Beneficial Effect of a Multistrain Synbiotic Prodefen ® Plus on the Systemic and Vascular Alterations Associated with Metabolic Syndrome in Rats : The Role of the Neuronal Nitric Oxide Synthase and Protein Kinase A
Llévenes, Pablo (Universidad Autónoma de Madrid. Departamento de Fisiología)
Rodrigues-Díez, Raquel (Instituto de Investigación Sanitaria del Hospital Universitario La Paz)
Cros-Brunsó, Laia (Universidad Autónoma de Madrid. Departamento de Fisiología)
Prieto, Mᵃ Isabel (Hospital Universitario La Paz (Madrid))
Casaní, Laura (Institut d'Investigació Biomèdica Sant Pau)
Balfagón, Gloria (Instituto de Investigación Sanitaria del Hospital Universitario La Paz)
Blanco-Rivero, Javier (Instituto de Investigación Sanitaria del Hospital Universitario La Paz)

Fecha:	2020
Resumen:	A high fat diet (HFD) intake is crucial for the development and progression of metabolic syndrome (MtS). Increasing evidence links gut dysbiosis with the metabolic and vascular alterations associated with MtS. Here we studied the use of a combination of various probiotic strains together with a prebiotic (synbiotic) in a commercially available Prodefen ® Plus. MtS was induced by HFD (45%) in male Wistar rats. Half of the MtS animals received Prodefen ® Plus for 4 weeks. At 12 weeks, we observed an increase in body weight, together with the presence of insulin resistance, liver steatosis, hypertriglyceridemia and hypertension in MtS rats. Prodefen ® Plus supplementation did not affect the body weight gain but ameliorated all the MtS-related symptoms. Moreover, the hypertension induced by HFD is caused by a diminished both nitric oxide (NO) functional role and release probably due to a diminished neuronal nitric oxide synthase (nNOS) activation by protein kinase A (PKA) pathway. Prodefen ® Plus supplementation for 4 weeks recovered the NO function and release and the systolic blood pressure was returned to normotensive values as a result. Overall, supplementation with Prodefen ® Plus could be considered an interesting non-pharmacological approach in MtS.
Nota:	This research was funded by Italfarmaco, S.A (L.O.U. 83; 0138/2018), CiberCV (Grant number: CB16/11/00286), the European Regional Development Grant (FEDER) (Comunidad de Madrid, Grant number B2017/BMD-3676), and R + D projects for young researchers, Universidad Autónoma de Madrid (Comunidad de Madrid (SI1-PJI-2019-00321). R.R.-D. received a fellowship from Juan de la Cierva Program (IJCI-2017-31399).
Nota:	Altres ajuts: FEDER/B2017/BMD-3676
Nota:	Altres ajuts: UAM/SI1-PJI-2019-00321
Nota:	Altres ajuts: JCP/IJCI-2017-31399
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	Metabolic syndrome ; Synbiotic ; Hypertension ; Superior mesenteric artery ; Perivascular nitrergic innervation ; Nitric oxide ; Neuronal nitric oxide synthase ; Protein kinase a
Publicado en:	Nutrients, Vol. 12 (january 2020) , ISSN 2072-6643

DOI: 10.3390/nu12010117
PMID: 31906276

18 p, 3.5 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados